Table 1.
Baseline characteristics of study population (N = 262)
| Baseline characteristics | |
|---|---|
| Mean age, y | 61.3 (35.5–82.6) |
| Male sex | 59 |
| BMI, kg/m2 | 29.35 (18.0–58.5) |
| Ethnicity | |
| African | 12.0 |
| Asian | 57.5 |
| Caucasian | 30.5 |
| Duration of T2DM, y | 13.71 (1–37) |
| Microvascular disease | 47.5 |
| Hyperlipidemia | 69.2 |
| HTN | 74.0 |
| HTN treatment | 74. |
| Medications | |
| Statin use | 72.1 |
| Oral hypoglycemics + insulin therapy | 27.5 |
| Insulin only | 6.1 |
| Oral hypoglycemics only | 65.2 |
| Smoking | 8.7 |
| Family history of ischemic heart disease | 43.4 |
| Family history of premature ischemic heart disease | 18.3 |
| SBP, mm Hg | 135.9 (90–180) |
| DBP, mm Hg | 84.1 (60–110) |
| HbA1c, mmol/mol | 65.2 (35.5–143.7) |
| CAC score, Au | |
| >0 | 200 (74) |
| >400 | 57 (22) |
| >1000 | 20 (9) |
Abbreviations: BMI, body mass index; CAC, coronary artery calcium; DBP, diastolic blood pressure; HbA1c, glycated hemoglobin; HTN, hypertension; IQR, interquartile range; SBP, systolic blood pressure; T2DM, type 2 diabetes mellitus.
Data are presented as %, n (%), or mean (IQR).